acyclovir

Generic: acyclovir

Labeler: nucare pharmaceuticals,inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acyclovir
Generic Name acyclovir
Labeler nucare pharmaceuticals,inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

acyclovir 200 mg/1

Manufacturer
NuCare Pharmaceuticals,Inc.

Identifiers & Regulatory

Product NDC 68071-2526
Product ID 68071-2526_2b12a92d-ff22-f428-e063-6294a90a3aee
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204313
Listing Expiration 2026-12-31
Marketing Start 2019-08-23

Pharmacologic Class

Established (EPC)
herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc]
Mechanism of Action
dna polymerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 680712526
Hyphenated Format 68071-2526

Supplemental Identifiers

RxCUI
197310
UPC
0368071252644
UNII
X4HES1O11F
NUI
N0000020060 N0000180187 N0000180188 N0000175468 N0000175459

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acyclovir (source: ndc)
Generic Name acyclovir (source: ndc)
Application Number ANDA204313 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (68071-2526-3)
  • 40 CAPSULE in 1 BOTTLE (68071-2526-4)
  • 60 CAPSULE in 1 BOTTLE (68071-2526-6)
source: ndc

Packages (3)

68071-2526-3 30 CAPSULE in 1 BOTTLE (68071-2526-3) 68071-2526-4 40 CAPSULE in 1 BOTTLE (68071-2526-4) 68071-2526-6 60 CAPSULE in 1 BOTTLE (68071-2526-6)

Ingredients (1)

acyclovir (200 mg/1)

Linked Drug Pages (1)

Acyclovir ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2b12a92d-ff22-f428-e063-6294a90a3aee", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0368071252644"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["cacaeb2a-6d3b-cf3e-e053-2a95a90a6ce4"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["NuCare Pharmaceuticals,Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (68071-2526-3)", "package_ndc": "68071-2526-3", "marketing_start_date": "20210830"}, {"sample": false, "description": "40 CAPSULE in 1 BOTTLE (68071-2526-4)", "package_ndc": "68071-2526-4", "marketing_start_date": "20210830"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (68071-2526-6)", "package_ndc": "68071-2526-6", "marketing_start_date": "20210830"}], "brand_name": "Acyclovir", "product_id": "68071-2526_2b12a92d-ff22-f428-e063-6294a90a3aee", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68071-2526", "generic_name": "Acyclovir", "labeler_name": "NuCare Pharmaceuticals,Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA204313", "marketing_category": "ANDA", "marketing_start_date": "20190823", "listing_expiration_date": "20261231"}